CNO Financial Group, Inc.

Listed Company

CNOCIK 0001224608NYSELarge AcceleratedAccident & Health InsuranceDelawareFY ends Dec 31

Period

FY 2025

Revenue

$4.49B

Net Income

$229.30M

Total Assets

$38.79B

Equity

$2.64B

Shares Out

93.35M

Op. Cash Flow

$675.70M

+ 13F Filer

CNO$53.57+42.45% · past yearDBEQ Basic

Daily closing prices

Business

CNO Financial Group is a holding company for insurance subsidiaries that develop, market and administer health insurance, annuity, individual life insurance and other financial services products. The company offers fixed indexed annuities, fixed interest annuities, supplemental health, Medicare supplement, long-term care, and life insurance products to middle-income pre-retirees and retired Americans. CNO operates through Consumer and Worksite Divisions, selling products via exclusive agents, independent producers and direct marketing across all fifty states and select U.S. territories.

Summary from 10-K filed 2026-02-24

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Insurance policy income	2,623	2,559	2,506	2,500	2,523
General account assets	1,542	1,419	1,250	1,179	1,140
Policyholder and other special-purpose portfolios	181	329	250	−163	281
Realized investment losses	−60	−76	−69	−18	21
Other investment gains	5	26	300,000	−118	−2
Total investment losses	−55	−50	−69	−135	19
Fee revenue and other income	196	192	211	197	159
Total revenues	4,487	4,450	4,147	3,577	4,122
Insurance policy benefits	2,548	2,450	2,331	1,617	2,188
Liability for future policy benefits remeasurement loss	−71	−41	−21	−16	−51
Change in fair value of market risk benefits	−12	−61	−34	−142	−23
Interest expense	231	254	239	137	95
Amortization of deferred acquisition costs and present value of future profits	278	251	227	213	198
Goodwill and other asset impairment	102	0	0	—	—
Gain on extinguishment of borrowings related to variable interest entities	−2	0	0	—	0
Other operating costs and expenses	1,120	1,055	1,048	951	982
Total benefits and expenses	4,194	3,910	3,790	2,760	3,389
Income before income taxes	293	540	357	817	733
Income tax expense	64	119	80	186	163
Net income	229	421	277	631	570
Weighted average shares outstanding (in shares)	98	106	113	116	128
Net income (in USD per share)	2.35	3.96	2.44	5.45	4.44
Weighted average shares outstanding (in shares)	100	108	115	118	131
Net income (in USD per share)	2.3	3.89	2.4	5.36	4.35

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: 2025 - $36.0 and 2024 - $37.1; amortized cost: 2025 - $25,776.4 and 2024 - $25,151.0)	23,887	22,730	21,506	20,353	24,805
Equity securities at fair value	389	272	97	135	131
Mortgage loans (net of allowance for credit losses: 2025 - $20.9 and 2024 - $13.6)	3,257	2,506	2,064	1,412	1,219
Policy loans	141	135	129	122	120
Trading securities	295	304	223	208	227
Investments held by variable interest entities (net of allowance for credit losses: 2025 - $0.6 and 2024 - $1.3; amortized cost: 2025 - $294.1 and 2024 - $437.0)	293	434	769	1,078	1,200
Other invested assets	1,737	1,492	1,353	1,035	1,224
Total investments	29,999	27,874	26,140	24,342	28,926
Cash and cash equivalents - unrestricted	956	1,657	775	576	632
Cash and cash equivalents held by variable interest entities	27	341	115	69	100
Accrued investment income	286	286	252	236	216
Present value of future profits	144	161	181	204	230
Deferred acquisition costs	2,397	2,159	1,944	1,771	1,112
Reinsurance receivables (net of allowance for credit losses: 2025 - $1.0 and 2024 - $3.0)	3,678	3,855	4,041	4,223	4,354
Income tax assets, net	713	814	936	1,063	118
Assets held in separate accounts	3	3	3	3	4
Other assets	588	700	641	581	519
Total assets	38,791	37,849	35,027	33,133	36,204
Policyholder account balances	18,913	17,594	15,223	15,234	13,690
Future policy benefits	11,898	11,706	—	—	—
Market risk benefit liability	48	60	117	11	—
Liability for life insurance policy claims	58	61	62	64	502
Unearned and advanced premiums	228	227	219	235	247
Liabilities related to separate accounts	3	3	3	3	4
Other liabilities	953	1,163	849	694	831
Investment borrowings	2,442	2,189	2,189	1,640	1,716
Borrowings related to variable interest entities	274	498	821	1,105	1,148
Notes payable direct corporate obligations	1,336	1,834	1,141	1,139	1,137
Total liabilities	36,152	35,334	32,812	31,364	30,945
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2025 - 94,484,339 and 2024 - 101,618,957)	900,000	1	1	1	1
Additional paid-in capital	1,336	1,633	1,892	2,034	2,184
Accumulated other comprehensive loss	−1,115	−1,371	−1,577	−1,957	1,947
Retained earnings	2,416	2,253	1,900	1,691	1,127
Total shareholders' equity	2,638	2,515	2,216	1,769	3,685
Total liabilities and shareholders' equity	38,791	37,849	35,027	33,133	36,204

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Insurance policy income	2,403	2,348	2,285	2,300	2,342
Net investment income	1,503	1,415	1,329	1,155	1,073
Fee revenue and other income	180	169	205	149	143
Insurance policy benefits	−1,629	−1,604	−1,611	−1,636	−1,661
Interest expense	−230	−259	−233	−121	−93
Deferrable policy acquisition costs	−499	−446	−378	−336	−304
Other operating costs	−1,014	−940	−956	−982	−921
Income taxes	−38	−55	−59	—	—
Net cash provided by operating activities	676	628	583	495	598
Sales of investments	3,275	3,240	1,389	3,254	1,824
Maturities and redemptions of investments	3,521	2,175	1,397	1,551	2,880
Purchases of investments	−8,460	−6,803	−3,592	−6,482	−6,135
Net purchases of trading securities	0	−88	−29	−42	−20
Other, net	−3	−14	−37	−61	−75
Net cash used by investing activities	−1,667	−1,489	−872	−1,781	−1,526
Issuance of notes payable, net	0	691	0	0	0
Payments on notes payable	−500	0	0	—	0
Issuance of common stock	12	11	13	14	22
Payments to repurchase common stock	−331	−300	−166	−190	−408
Common stock dividends paid	−66	−68	−68	−65	−66
Amounts received for deposit products	3,234	3,932	2,112	3,023	2,405
Withdrawals from deposit products	−2,386	−1,962	−1,696	−1,461	−1,353
Proceeds from financing arrangements	0	0	80	0	0
Payments on financing arrangements	−15	−14	−6	0	0
Federal Home Loan Bank	777	612	996	285	796
Related to variable interest entities	0	276	0	0	—
Federal Home Loan Bank	−524	−613	−446	−361	−722
Related to variable interest entities and other	−223	−597	−285	−44	−5
Net cash (used) provided by financing activities	−23	1,970	534	1,199	668
Net (decrease) increase in cash and cash equivalents	−1,014	1,109	244	−87	−260

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Holdings (13F)

Portfolio as of 2026-03-31 · 18 positions

Reported AUM

$174.42M

Holdings

Top sector

$174.42M

Top sectors

Sector	Value	% of portfolio
Uncategorized	$174.42M	100.0%

Top holdings

Issuer	Ticker	Shares	Value	%
SPDR SERIES TRUST	—	700.0K	$21.59M	12.4%
SSGA ACTIVE ETF TR	—	505.0K	$20.27M	11.6%
INVESCO EXCH TRADED FD TR II	—	940.0K	$19.18M	11.0%
SPDR SERIES TRUST	—	648.0K	$15.11M	8.7%
SSGA ACTIVE ETF TR	—	357.0K	$14.33M	8.2%
INVESCO EXCH TRADED FD TR II	—	662.0K	$13.51M	7.8%
ISHARES TR	—	320.0K	$11.79M	6.8%
SPDR SERIES TRUST	—	105.5K	$10.10M	5.8%
SPDR SERIES TRUST	—	420.0K	$9.79M	5.6%
FIRST TR EXCHANGE-TRADED FD	—	152.0K	$6.81M	3.9%

Frequently asked questions

What is CNO Financial Group, Inc.'s CIK number?

CNO Financial Group, Inc.'s SEC CIK number is 0001224608 (1224608). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find CNO Financial Group, Inc.'s SEC filings?

All of CNO Financial Group, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did CNO Financial Group, Inc. last report earnings?

CNO Financial Group, Inc. (CNO) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001224608-26-000038). This is CNO Financial Group, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is CNO Financial Group, Inc.'s most recent earnings 8-K?

CNO Financial Group, Inc.'s latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001224608-26-000038. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View CNO Financial Group, Inc.'s latest earnings 8-K →
Look up any company's CIK number →